Chr. Hansen HMO GmbH was founded in 2005 and is engaged in the development, approval, production and worldwide marketing of biotechnologically produced mono- and oligosaccharides. The business model also includes contract development and the granting of licenses on certain intellectual property rights. The company operates an industrial-scale production facility for human milk oligosaccharides in Rheinbreitbach. The in-house development department averaged 26 employees in the short fiscal year; R&D costs in the short fiscal year 2023 amounted to 1,399 T€, of which 200 T€ were capitalised.
Biotechnische Forschung, Entwicklung, Herstellung und Vermarktung von Produkten, insbesondere Zwischenprodukten, Zusatzstoffen und Laborchemikalien für die pharmazeutische, chemische sowie Nahrungsmittel- und Kosmetikindustrie.
This summary was generated with the help of AI. See our Data Quality Notice. Report error?
Source: German Commercial Register (Handelsregister) Montabaur Local Court, HRB 20721 (as of 1 October 2026)
Source: German Commercial Register (Handelsregister) Montabaur Local Court, HRB 20721 (as of 1 October 2026)
Source: German Commercial Register (Handelsregister) Montabaur Local Court, HRB 20721 (as of 1 October 2026)
Sign in to download data
Source: German Commercial Register (Handelsregister) Montabaur Local Court, HRB 20721 (as of 1 October 2026)
MTS Systems (Germany) GmbH
Berlin · Sonstige Forschung und Entwicklung im Bereich Natur-, Ingenieur-, Agrarwissenschaften und Medizin
Hasso-Plattner-Institut für Digital Engineering gGmbH
Potsdam · Sonstige Forschung und Entwicklung im Bereich Natur-, Ingenieur-, Agrarwissenschaften und Medizin
ProBioGen AG
Berlin · Forschung und Entwicklung im Bereich Biotechnologie
Sign in to view detailed salary and cost trends.
